Advertisement SIPO issues new patent for Aoxing Pharma psychotropic drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SIPO issues new patent for Aoxing Pharma psychotropic drug

The State Intellectual Property Office (SIPO) of The People's Republic of China has issued a new patent ZL2006.1.0075080.2 to Aoxing Pharmaceutical for its psychotropic drug midazolam maleate oral film.

The new patent covers an oral film formulation of midazolam maleate that can be dissolved rapidly under the tongue.

The company anticipates that the improved formulation would allow the drug to be used for all kinds of insomnia, sleep rhythm disorder, anxiety, minor operation and endoscopy.

Aoxing Pharma is engaged in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.